# MARINUS PHARMACEUTICALS, INC.

MARINUS PHARMACEUTICALS, INC. is a company headquartered in Radnor, PA, United States.

## Company overview

- **Legal name:** MARINUS PHARMACEUTICALS, INC.
- **Former names in filing history:** MARINUS PHARMACEUTICALS INC (2003-10-22 to 2022-03-31)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Radnor, PA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001267813

## About

MARINUS PHARMACEUTICALS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001267813, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-03-05, it reported annual revenue of USD 30,989,000; net income of USD -141,405,000; total assets of USD 170,908,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $31.0M (USD 30,989,000)
- **Net income:** -$141.4M (USD -141,405,000)
- **Total assets:** $170.9M (USD 170,908,000)
- **Cash and equivalents:** $120.6M (USD 120,572,000)
- **Operating cash flow:** -$118.0M (USD -118,001,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $25.5M (USD 25,478,000)
- **Net income:** -$19.8M (USD -19,816,000)
- **Total assets:** $259.5M (USD 259,518,000)
- **Cash and equivalents:** $240.6M (USD 240,551,000)
- **Operating cash flow:** -$112.9M (USD -112,886,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $15.3M (USD 15,345,000)
- **Net income:** -$98.8M (USD -98,776,000)
- **Total assets:** $136.8M (USD 136,840,000)
- **Cash and equivalents:** $122.9M (USD 122,927,000)
- **Operating cash flow:** -$55.5M (USD -55,477,000)

### FY2020 (period ended 2020-12-31)

- **Net income:** -$67.5M (USD -67,475,000)
- **Total assets:** $150.5M (USD 150,462,000)
- **Cash and equivalents:** $138.5M (USD 138,509,000)
- **Operating cash flow:** -$60.9M (USD -60,912,000)

## Recent SEC filings

- Form 8-K — filed 2025-02-11 — period 2025-02-07 — FORM 8-K
- Form 8-K — filed 2024-12-30 — period 2024-12-29 — FORM 8-K
- Form 8-K — filed 2024-12-30 — period 2024-12-23 — FORM 8-K
- Form 8-K — filed 2024-12-23 — period 2024-12-17 — 8-K
- Form 8-K — filed 2024-12-10 — period 2024-12-06 — 8-K
- Form 8-K — filed 2024-11-15 — period 2024-11-14 — 8-K
- Form SC 13G — filed 2024-11-14
- Form 10-Q — filed 2024-11-12 — period 2024-09-30 — 10-Q
- Form 8-K — filed 2024-11-12 — period 2024-11-12 — 8-K
- Form SC 13G — filed 2024-11-01 — SC 13G
- Form 8-K — filed 2024-10-24 — period 2024-10-24 — 8-K
- Form 8-K — filed 2024-10-02 — period 2024-10-02 — 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/marinus-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology